Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activities
The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Recombinant human erythropoietin (rhEPO) is receiving increasing attention as a potential therapy for prevention of injury and restoration of function in nonhematopoietic tissues. However, the minimum effective dose required to mimic and augment these normal paracrine functions of erythropoietin (EPO) in some organs (e.g., the brain) is higher than for treatment of anemia. Notably, a dose-dependent risk of adverse effects has been associated with rhEPO administration, especially in high-risk groups, including polycythemia–hyperviscosity syndrome, hypertension, and vascular thrombosis. Of note, several clinical trials employing relatively high dosages of rhEPO in oncology patients were recently halted after an increase in mortality and morbidity, primarily because of thrombotic events. We recently identified a heteromeric EPO receptor complex that mediates tissue protection and is distinct from the homodimeric receptor responsible for the support of erythropoiesis. Moreover, we developed receptor-selective ligands that provide tools to assess which receptor isoform mediates which biological consequence of rhEPO therapy. Here, we demonstrate that rhEPO administration in the rat increases systemic blood pressure, reduces regional renal blood flow, and increases platelet counts and procoagulant activities. In contrast, carbamylated rhEPO, a heteromeric receptor-specific ligand that is fully tissue protective, increases renal blood flow, promotes sodium excretion, reduces injury-induced elevation in procoagulant activity, and does not effect platelet production. These preclinical findings suggest that nonerythropoietic tissue-protective ligands, which appear to elicit fewer adverse effects, may be especially useful in clinical settings for tissue protection.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Erythropoietin was originally recognized via its role in erythropoiesis [2145-2147] (hence its name, of course), but it has become evident that it has many other roles, and in particular it is observed phenomenologically that erythropoietin (and non-erthyropoetic derivatives) is protective in a number of inflammatory conditions that accompany many diseases such as those listed above [940,942,2148-”
From Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (2009) · cites this paper as [2153]
Citations
Cites
Correction of the Anemia of End-Stage Renal Disease with Recombinant Human Erythropoietin
Eschbach, J. W., Egrie, J. C., Downing, M. R., Browne, J. K., & Adamson, J. W. (1987) · New England Journal of Medicine · doi:10.1056/nejm198701083160203 · Cited by 2,005
Besarab, A., Bolton, W. K., Browne, J. K., Egrie, J. C., Nissenson, A. R., Okamoto, D. M., Schwab, S. J., & Goodkin, D. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808273390903 · Cited by 1,930
Henke, M., Laszig, R., Rübe, C., Schäfer, U., Haase, K.-D., Schilcher, B., Mose, S., Beer, K. T., Burger, U., Dougherty, C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14567-9 · Cited by 1,250
Kalantar-Zadeh, K. (2017) · American Journal of Nephrology · doi:10.1159/000455387 · Cited by 1,148
Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
Ehrenreich, H., Hasselblatt, M., Dembowski, C., Cepek, L., Lewczuk, P., Stiefel, M., Rustenbeck, H.-H., Breiter, N., Jacob, S., Knerlich, F., et al. (2002) · Molecular Medicine · doi:10.1007/bf03402029 · Cited by 1,028
Self-citationDerivatives of Erythropoietin That Are Tissue Protective But Not Erythropoietic
Leist, M., Ghezzi, P., Grasso, G., Bianchi, R., Villa, P., Fratelli, M., Savino, C., Bianchi, M., Nielsen, J., Gerwien, J., et al. (2004) · Science · doi:10.1126/science.1098313 · Cited by 803
Self-citationErythropoietin: Physiology and Pharmacology Update
Fisher, J. W. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800101 · Cited by 708
Jones, M., Ibels, L., Schenkel, B., & Zagari, M. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00450.x · Cited by 665
Brines, M., Grasso, G., Fiordaliso, F., Sfacteria, A., Ghezzi, P., Fratelli, M., Latini, R., Xie, Q.-W., Smart, J., Su-Rick, C.-J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406491101 · Cited by 656
Self-citationRisk factors for chemotherapy‐associated venous thromboembolism in a prospective observational study
Khorana, A. A., Francis, C. W., Culakova, E., & Lyman, G. H. (2005) · Cancer · doi:10.1002/cncr.21496 · Cited by 565
Research works printed but not linked: 6
- D. Santini, B. Vincenzi, A. La Cesa, V. Virzi, F. Navajas, V. Malafarina, G. Dicuonzo, R. Cassandro, V. Esposito, V. Montesarchio, et al. Anticancer Res 25, 669–674 (2005).
- N. D. Vaziri, X. J. Zhou, J. Smith, F. Oveisi, K. Baldwin, R. E. Purdy Am. J. Physiol 269, F838–F845 (1995).
- M. Nowicki J. Hum. Hypertens 9, 81–88 (1995).
- A. Lin, J. Ryu, D. Harvey, B. Sieracki, S. Scudder, T. Wun Gynecol. Oncol, 2006).
- 10.1016/s0008-6363(96)00066-1 · doi:10.1016/s0008-6363(96)00066-1 · Paper page
- 10.1093/oxfordjournals.ndt.a027361 · doi:10.1093/oxfordjournals.ndt.a027361 · Paper page
Cited by
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
“[1972] Coleman, T.”
The non‐haematopoietic biological effects of erythropoietin
Arcasoy, M. O. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07014.x · Cited by 347
Brines, M., & Cerami, A. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.02024.x · Cited by 333
Self-citationSimon, F., Scheuerle, A., Gröger, M., Vcelar, B. A., McCook, O., Möller, P., Georgieff, M., Calzia, E., Radermacher, P., & Schelzig, H. (2011) · Intensive Care Medicine · doi:10.1007/s00134-011-2303-4 · Cited by 315
Erythropoietin and renoprotection
Bahlmann, F. H., & Fliser, D. (2008) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e32831a9dde · Cited by 300
Discovering erythropoietin's extra-hematopoietic functions: Biology and clinical promise
Brines, M., & Cerami, A. (2006) · Kidney International · doi:10.1038/sj.ki.5001546 · Cited by 290
Self-citationNeural stem cell therapies and hypoxic-ischemic brain injury
Huang, L., & Zhang, L. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.05.004 · Cited by 211
Kotsch, K., Ulrich, F., Reutzel-Selke, A., Pascher, A., Faber, W., Warnick, P., Hoffman, S., Francuski, M., Kunert, C., Kuecuek, O., et al. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e318190e70c · Cited by 198
From oxygen to erythropoietin: Relevance of hypoxia for retinal development, health and disease
Caprara, C., & Grimm, C. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.11.003 · Cited by 176
Carbamylation and antibodies against carbamylated proteins in autoimmunity and other pathologies
Shi, J., van Veelen, P. A., Mähler, M., Janssen, G. M. C., Drijfhout, J. W., Huizinga, T. W. J., Toes, R. E. M., & Trouw, L. A. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.10.008 · Cited by 167
van der Kooij, M. A., Groenendaal, F., Kavelaars, A., Heijnen, C. J., & van Bel, F. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.04.007 · Cited by 163
Anaemia management and mortality risk in chronic kidney disease
Hörl, W. H. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.21 · Cited by 155
Mechanism of Increased Mortality Risk with Erythropoietin Treatment to Higher Hemoglobin Targets
Fishbane, S. N., & Besarab, A. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02380607 · Cited by 144
New Insights into Nephrogenic Systemic Fibrosis
Swaminathan, S., & Shah, S. V. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007060645 · Cited by 132
Plasticity and remodeling of brain
Chopp, M., Li, Y., & Zhang, J. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.06.013 · Cited by 122
McVicar, C., Hamilton, R. W., Colhoun, L. M., Gardiner, T. A., Brines, M. L., Cerami, A., & Stitt, A. W. (2011) · Diabetes · doi:10.2337/db11-0026 · Cited by 119
Self-citationAutoantibodies to Posttranslational Modifications in Rheumatoid Arthritis
Burska, A. N., Hunt, L., Boissinot, M., Strollo, R., Ryan, B. J., Vital, E., Nissim, A., Winyard, P. G., Emery, P., & Ponchel, F. (2014) · Mediators of Inflammation · doi:10.1155/2014/492873 · Cited by 92
Kidney grafts from brain dead donors: Inferior quality or opportunity for improvement?
Bos, E. M., Leuvenink, H. G. D., van Goor, H., & Ploeg, R. J. (2007) · Kidney International · doi:10.1038/sj.ki.5002400 · Cited by 89
Self-citationErythropoietin 2nd cerebral protection after acute injuries: A double-edged sword?
Velly, L. J., Pellegrini, L., Guillet, B. A., Bruder, N. J., & Pisano, P. S. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.08.002 · Cited by 89
Asialoerythropoietin Prevents Contrast-Induced Nephropathy
Yokomaku, Y., Sugimoto, T., Kume, S., Araki, S., Isshiki, K., Chin‒Kanasaki, M., Sakaguchi, M., Nitta, N., Haneda, M., Koya, D., et al. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007040481 · Cited by 88
A review of published reports on neuroprotection in spinal cord injury
Onose, G., Anghelescu, A., Muresanu, D. F., Pădure, L., Haras, M., Chendreanu, C., Onose, L., Mirea, A., Ciurea, A. V., Masri, W. S. E., et al. (2009) · Spinal Cord · doi:10.1038/sc.2009.52 · Cited by 84
Sanchez, P. E., Navarro, F. P., Farès, R., Nadam, J., Georges, B., Moulin, C., Cavorsin, M. L., Bonnet, C., Ryvlin, P., Belmeguenaï, A., et al. (2009) · The Journal of Comparative Neurology · doi:10.1002/cne.22020 · Cited by 72
Darbepoetin alfa protects podocytes from apoptosis in vitro and in vivo
Logar, C. M., Brinkkoetter, P. T., Krofft, R. D., Pippin, J. W., & Shankland, S. J. (2007) · Kidney International · doi:10.1038/sj.ki.5002362 · Cited by 70
Ueba, H., Brines, M. L., Yamin, M., Umemoto, T., Ako, J., Momomura, S., Cerami, A., & Kawakami, M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003019107 · Cited by 67
Self-citationSingh, A. K. (2010) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e32833cf1d6 · Cited by 66
Erythropoietin and the heart: Physiological effects and the therapeutic perspective
Sanchis‐Gomar, F., García‐Giménez, J. L., Pareja-Galeano, H., Romagnoli, M., Pérez-Quilis, C., & Lippi, G. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.12.011 · Cited by 66
Torup, L., Bochsen, L., Kjalke, M., Abel, K. L., Theilgaard‐Mönch, K., Johansson, P. I., Bjørn, S. E., Kirkeby, A., Gerwien, J. G., & Leist, M. (2008) · Thrombosis and Haemostasis · doi:10.1160/th07-03-0208 · Cited by 65
Carbamylated Erythropoietin Reduces Radiosurgically-Induced Brain Injury
Erbayraktar, S., de Lanerolle, N. C., de Lotbinière, A., Knisely, J. P. S., Erbayraktar, Z., Yılmaz, O., Cerami, A., Coleman, T. R., & Brines, M. L. (2006) · Molecular Medicine · doi:10.2119/2006-00042.erbayraktar · Cited by 61
Self-citationChamorro, M. E., Wenker, S. D., Vota, D., Vittori, D. C., & Nesse, A. B. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.04.006 · Cited by 61
Xu, X., Cao, Z., Cao, B., Li, J., Guo, L., Que, L., Ha, T., Chen, Q., Li, C., & Li, Y. (2009) · Surgery · doi:10.1016/j.surg.2009.03.022 · Cited by 59
Recent advances and clinical application of erythropoietin and erythropoiesis-stimulating agents
Tanaka, T., & Nangaku, M. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.02.035 · Cited by 58
Role of endotoxin and cytokines in the systemic inflammatory response to heat injury
Leon, L. R., & Helwig, B. G. (2010) · Frontiers in Bioscience-Scholar · doi:10.2741/s111 · Cited by 57
Can erythropoietin be used to prevent brain damage in cerebral malaria?
Casals‐Pascual, C., Idro, R., Picot, S., Roberts, D. J., & Newton, C. R. J. C. (2008) · Trends in Parasitology · doi:10.1016/j.pt.2008.10.002 · Cited by 55
Erythroid-Stimulating Agents in Cancer Therapy: Potential Dangers and Biologic Mechanisms
Hadland, B., & Longmore, G. D. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.6945 · Cited by 54
Effects of erythropoietin on the bone microenvironment
McGee, S., Havens, A. M., Shiozawa, Y., Jung, Y., & Taichman, R. S. (2011) · Growth Factors · doi:10.3109/08977194.2011.637034 · Cited by 54
EPO: renoprotection beyond anemia correction
Fliser, D., Bahlmann, F. H., & Haller, H. G. (2006) · Pediatric Nephrology · doi:10.1007/s00467-006-0284-2 · Cited by 53
Nonerythropoietic Tissue Protective Compounds Are Highly Effective Facilitators of Wound Healing
Erbayraktar, Z., Erbayraktar, S., Yılmaz, O., Cerami, A., Coleman, T. R., & Brines, M. L. (2009) · Molecular Medicine · doi:10.2119/molmed.2009.00051 · Cited by 51
Self-citationErythropoietin: A Candidate Neuroprotective Agent in the Treatment of Glaucoma
Tsai, J. C., Song, B. J., Wu, L., & Forbes, M. (2007) · Journal of Glaucoma · doi:10.1097/ijg.0b013e318156a556 · Cited by 48
Fliser, D. (2010) · Journal of Nephrology · doi:10.1093/joneph/23.4.369 · Cited by 48
Factor analysis of various anaerobic power tests.
Manning, J. M., DOOLY-MANNING, C. R., & Perrin, D. H. (1988) · PubMed · Cited by 48
Hand, C. C., & Brines, M. L. (2011) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e3181ed30bf · Cited by 47
Self-citationKako, E., Kaneko, N., Aoyama, M., Hida, H., Takebayashi, H., Ikenaka, K., Asai, K., Togari, H., Sobue, K., & Sawamoto, K. (2012) · Stem Cells · doi:10.1002/stem.1202 · Cited by 44
Sorg, H., Harder, Y., Krueger, C., Reimers, K., & Vogt, P. M. (2012) · Medicinal Research Reviews · doi:10.1002/med.21259 · Cited by 42
Silva, I., Alípio, C., Pinto, R. M. A., & Mateus, V. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111558 · Cited by 41
Liem, A. H., van de Woestijne, A. P., Bruijns, E., van Lennep, H. W. O. R., de Boo, J. A. J., van Halteren, H. K., van Es, T. P., Jukema, J. W., van der Laarse, A., Zwinderman, A. H., et al. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.07.076 · Cited by 41
Matějková, Š., Scheuerle, A., Wagner, F., McCook, O., Matallo, J., Gröger, M., Seifritz, A., Stahl, B., Vcelar, B. A., Calzia, E., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2766-y · Cited by 37
Tayra, J. T., Kameda, M., Yasuhara, T., Agari, T., Kadota, T., Wang, F., Kikuchi, Y., Liang, H., Shinko, A., Wakamori, T., et al. (2013) · Brain Research · doi:10.1016/j.brainres.2013.01.042 · Cited by 35
Brar, S. K., Perveen, S., Chaudhry, M. R., Albabtain, S., Amreen, S., & Khan, S. (2021) · Cureus · doi:10.7759/cureus.12804 · Cited by 35
Erythropoietin and progression of CKD
Bahlmann, F. H., Kielstein, J. T., Haller, H. G., & Fliser, D. (2007) · Kidney International · doi:10.1038/sj.ki.5002484 · Cited by 33
van Rijt, W. G., van Goor, H., Ploeg, R. J., & Leuvenink, H. G. D. (2013) · Transplant International · doi:10.1111/tri.12174 · Cited by 33
Self-citationErythropoietin and cerebral vascular protection: role of nitric oxide
Santhanam, A. V. R., & Katušić, Z. S. (2006) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2006.00441.x · Cited by 32
Bench to bedside: A role for erythropoietin in sepsis
Walden, A. P., Young, D., & Sharples, E. J. (2010) · Critical Care · doi:10.1186/cc9049 · Cited by 29
Hache, G., Garrigue, P., Bennis, Y., Stalin, J., Moyon, A., Cerami, A., Brines, M. L., Blot‐Chabaud, M., Sabatier, F., Dignat‐George, F., et al. (2016) · Shock · doi:10.1097/shk.0000000000000606 · Cited by 29
Self-citationTogel, F. E., Ahlstrom, J. D., Yang, Y., Hu, Z., Zhang, P., & Westenfelder, C. S. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015091059 · Cited by 26
Self-citationErythropoietin Promotes Neurological Recovery after Intracerebral Haemorrhage in Rats
Seyfried, D. M., Han, Y., Yang, D., Ding, J., & Chopp, M. (2009) · International Journal of Stroke · doi:10.1111/j.1747-4949.2009.00292.x · Cited by 25
The mortality risk associated with higher hemoglobin: is the therapy to blame?
Rosner, M. H., & Bolton, W. K. (2008) · Kidney International · doi:10.1038/ki.2008.263 · Cited by 25
Diao, M., Qu, Y., Liu, H., Ma, Y., & Lin, X. (2019) · Biological Research · doi:10.1186/s40659-019-0234-7 · Cited by 25
Roskott, A. M., Nieuwenhuijs, V. B., Leuvenink, H. G. D., Dijkstra, G. D. H., Ottens, P. J., de Jager, M. H., Pereira, P. G. D., Fidler, V., Groothuis, G. M. M., Ploeg, R. J., et al. (2010) · Transplantation · doi:10.1097/tp.0b013e3181ebf796 · Cited by 25
Self-citationChang, J.-R., Sun, N., Liu, Y., Wei, M., Zhao, Y., Gan, L., Zhu, J.-X., & Su, X. (2019) · Peptides · doi:10.1016/j.peptides.2019.170181 · Cited by 23
Biology of Erythropoiesis, Erythroid Differentiation, and Maturation
Papayannopoulou, T., & Migliaccio, A. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35762-3.00026-3 · Cited by 24
Carbamoylated erythropoietin induces a neurotrophic gene profile in neuronal cells
Tiwari, N. K., Sathyanesan, M., Schweinle, W. E., & Newton, S. S. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.07.011 · Cited by 23
Bitto, A., Irrera, N., Pizzino, G., Pallio, G., Mannino, F., Vaccaro, M., Arcoraci, V., Aliquò, F., Minutoli, L., Colonna, M. R., et al. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.12.006 · Cited by 22
Self-citationHeikal, L., Ghezzi, P., Mengozzi, M., Stelmaszczuk, B., Feelisch, M., & Ferns, G. A. (2016) · Hypoxia · doi:10.2147/hp.s104377 · Cited by 22
Self-citationErythropoiesis-stimulating agents: Past and future
Nangaku, M., & Fliser, D. (2007) · Kidney International · doi:10.1038/sj.ki.5002480 · Cited by 21
Shen, S., Jin, Y., Li, W., Liu, X., Zhang, T., Xia, W., Wang, Y., & Ma, K. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000542 · Cited by 21
Erythropoietin and the endothelium – a promising link?
Fliser, D., & Bahlmann, F. H. (2008) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2008.01968.x · Cited by 21
Emerging technologies in the delivery of erythropoietin for therapeutics
Murua, A., Orive, G., Hernández, R. M., & Pedraz, J. L. (2011) · Medicinal Research Reviews · doi:10.1002/med.20184 · Cited by 20
Erythropoietin for the Treatment of Subarachnoid Hemorrhage: A Review
Turner, J. D., Mammis, A., & Prestigiacomo, C. J. (2010) · World Neurosurgery · doi:10.1016/j.wneu.2010.02.026 · Cited by 20
O'Leary, O. E., Canning, P., Reid, E., Bertelli, P. M., McKeown, S., Brines, M. L., Cerami, A., Du, X., Xu, H., Chen, M., et al. (2019) · Experimental Eye Research · doi:10.1016/j.exer.2019.03.001 · Cited by 20
Self-citationIs there a role for erythropoietin in cardiovascular disease?
Vogiatzi, G., Briasoulis, Α., Tousoulis, D., Παπαγεωργίου, Ν., & Stefanadis, C. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590903547819 · Cited by 20
Miller, J. L., Church, T. J., Leonoudakis, D., Lariosa-Willingham, K. D., Frigon, N. L., Tettenborn, C. S., Spencer, J. R., & Punnonen, J. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.098400 · Cited by 20
He, H., QIAO, X., & Sui-sheng, W. (2013) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2013.1134 · Cited by 19
Madonna, R., Shelat, H. S., Xue, Q., Willerson, J. T., Caterina, R. D., & Geng, Y. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.07.016 · Cited by 19
Chen, C., Chou, K.-J., Lee, P., Chen, Y.-S., Chang, T.-Y., Hsu, C., Huang, W.-C., Chung, H., & Fang, H.-C. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.02.022 · Cited by 18
Carbamoylated erythropoietin produces antidepressant-like effects in male and female mice
Sampath, D., McWhirt, J., Sathyanesan, M., & Newton, S. S. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109754 · Cited by 16
Effect of normovolemic hematocrit changes on blood pressure and flow
Bonnin, P., Vilar, J., & Levy, B. I. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.01.050 · Cited by 16
Hooshmandi, E., Moosavi, M., Katinger, H. W. D., Sardab, S., Ghasemi, R., & Maghsoudi, N. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05309-6 · Cited by 16
Chattong, S., Tanamai, J., Kiatsomchai, P., Nakatsu, M., Sereemaspun, A., Pimpha, N., Praditpornsilpa, K., Rojanathanes, R., Sethpakadee, A., Tungsanga, K., et al. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02123.x · Cited by 16
Cao, S. L., Ren, Y., Li, Z., Lin, J., Weng, X. S., & Feng, B. (2019) · QJM · doi:10.1093/qjmed/hcz261 · Cited by 16
Erythropoietin induces positive inotropic and lusitropic effects in murine and human myocardium
Hefer, D., Yi, T., Selby, D. E., Fishbaugher, D. E., Tremble, S. M., Begin, K. J., Gogo, P. B., LeWinter, M. M., Meyer, M., Palmer, B. M., et al. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.10.005 · Cited by 15
Erythropoietin Protects Against Acute Kidney Injury and Failure
Johnson, D. W., Vesey, D. A., & Gobe, G. C. (2010) · The Open Drug Discovery Journal · doi:10.2174/1877381801002020008 · Cited by 14
Erythropoietin ameliorates chemotherapy‐induced fibrosis of the lungs in a preclinical murine model
Sigounas, G., Salleng, K. J., Mehlhop, P. D., & Sigounas, D. G. (2008) · International Journal of Cancer · doi:10.1002/ijc.23426 · Cited by 14
Kang, H., & Kim, H.-S. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.5.703 · Cited by 13
Differential effect of erythropoietin and carbamylated erythropoietin on endothelial cell migration
Maltaneri, R. E., Chamorro, M. E., Schiappacasse, A., Nesse, A. B., & Vittori, D. C. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.01.013 · Cited by 13
Deng, Q., Parker, E. J., Duan, R., & Yang, L. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04896-4 · Cited by 11
Chamorro, M. E., Maltaneri, R. E., Vittori, D. C., & Nesse, A. B. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.01.019 · Cited by 11
Bone mass gain after parathyroidectomy
Pasch, A. (2008) · Kidney International · doi:10.1038/ki.2008.321 · Cited by 9
Ulusal, I., Tari, R., Öztürk, G., Ayçiçek, E., Aktar, F., Kotıl, K., Bılge, T., & Kırış, T. (2010) · Acta Neurochirurgica · doi:10.1007/s00701-010-0775-6 · Cited by 7
Endotoxin-induced cerebral pathophysiology: differences between fetus and newborn
Feng, S. Y. S., Hollis, J. H., Samarasinghe, T. D., Phillips, D. J., Rao, S. C., YU, V. Y. H., & WALKER, A. M. (2019) · Physiological Reports · doi:10.14814/phy2.13973 · Cited by 7
Do Erythropoietin Receptors on Cancer Cells Explain Unexpected Clinical Findings?
Clavo, B. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.9713 · Cited by 7
Heikal, L., Ghezzi, P., Mengozzi, M., & Ferns, G. A. (2015) · Molecular Medicine · doi:10.2119/molmed.2015.00162 · Cited by 6
Self-citationMaltaneri, R. E., Chamorro, M. E., Gionco, S., Nesse, A. B., & Vittori, D. C. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2024.119800 · Cited by 5
Erythropoietin in the Neurology ICU
Robertson, C. S., & Sadrameli, S. S. (2013) · Current Treatment Options in Neurology · doi:10.1007/s11940-013-0222-0 · Cited by 5
Aachmann‐Andersen, N. J., Christensen, S. J., Lisbjerg, K., Oturai, P., Johansson, P. I., Holstein‐Rathlou, N., & Olsen, N. V. (2018) · Physiological Reports · doi:10.14814/phy2.13573 · Cited by 5
Taşar, P. T., & Ozen, Y. (2022) · Experimental and Clinical Transplantation · doi:10.6002/ect.2021.0425 · Cited by 5
Biological and physical strategies to improve the therapeutic index of photodynamic therapy.
Rendon, C. A. (2008) · TSpace (University of Toronto) · Cited by 4
BENEFICIAL EFFECTS OF ERYTHROPOIETIN IN MODELS OF SHOCK AND ORGAN FAILURE-NOTHING IS SIMPLE AND EASY
Simon, F., Calzia, E., Radermacher, P., & Schelzig, H. (2009) · Shock · doi:10.1097/shk.0b013e3181890733 · Cited by 4
Safety Concerns With the Clinical Use of Erythropoietin in Acute Ischemic Stroke
Kumral, A., Genç, Ş., Kutluk, K., & Özkan, H. (2010) · Stroke · doi:10.1161/strokeaha.110.585943 · Cited by 4
Kim, E. J., Park, K. K., Choi, S. Y., Ju, H. M., Kim, T. L., Kim, J., Kim, S. Y., & Koo, B. (2024) · BMC Anesthesiology · doi:10.1186/s12871-024-02770-9 · Cited by 3
Saqib, N. U., Duling, L. C., Krier, K., & Howdieshell, T. R. (2009) · PubMed · Cited by 3
Metadata
- Authors
- Coleman, T. R., Westenfelder, C., Tögel, F. E., Yang, Y., Hu, Z., Swenson, L., Leuvenink, H. G. D., Ploeg, R. J., d’Uscio, L. V., Katusic, Z. S., Ghezzi, P., Zanetti, A., Kaushansky, K., Fox, N. E., Cerami, A., & Brines, M.
- Affiliations
- Verona Pharma (United Kingdom) (GB)
- University of Utah (US)
- Departments of Medicine and Physiology, University of Utah and Veterans Affairs Medical Centers, Salt Lake City, UT 84148;
- University of Groningen (NL)
- Mayo Clinic (US)
- University of Groningen, 9700 AB, Groningen, The Netherlands;
- Mario Negri Institute for Pharmacological Research (IT)
- University of California San Diego (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2006-04-11
- Volume
- 103
- Issue
- 15
- Pages
- 5965-5970
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2106292297
- Cited by
- 127
- References
- 62
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 3 · 2020: 2 · 2019: 6 · 2018: 4 · 2017: 4 · 2016: 5 · 2015: 3 · 2014: 5 · 2013: 9 · 2012: 7
- FWCI
- 9.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
- CINECA IRIS Institutional Research information system (University of Urbino) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Funders
- National Cancer Institute (R01CA031615)
- Topics
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Life Sciences › Immunology and Microbiology › Immunology › Biosimilars and Bioanalytical Methods
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Keywords
- recombinant human erythropoietin, carbamylated erythropoietin, erythropoietin receptor, heteromeric receptors, procoagulant activity, platelet count, blood pressure, renal blood flow, sodium excretion, tissue protection, thrombosis, dose-dependent adverse effects, paracrine effects
- MeSH terms
- Animals, Blood Coagulation, Blood Pressure, Bone Marrow Cells, Cell Line, Coagulants, Endothelium, Vascular, Erythropoietin, Hematopoiesis, Hemodynamics, Humans, Renal Circulation, Stem Cells, Umbilical Veins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.